PorA variable regions of Neisseria meningitidis - PubMed (original) (raw)

PorA variable regions of Neisseria meningitidis

Joanne E Russell et al. Emerg Infect Dis. 2004 Apr.

Abstract

Subtypes, defined by variation in the outer membrane protein PorA, are an integral part of the characterization scheme for Neisseria meningitidis. Identification of these variants remains important as the PorA protein is a major immunogenic component of several meningococcal vaccines under development, and characteristics of PorA are used to provide detailed epidemiologic information. Historically, serosubtypes have been defined by reactivity with a set of monoclonal antibodies. However, nucleotide sequence analyses of porA genes have established that the panel of serosubtyping monoclonal antibodies is not exhaustive, and many porA variants cannot be detected. In addition, the nomenclature system used to define subtypes is inadequate. We examined all available nucleotide sequences of the porA VR1 and VR2 regions to identify and define subtype families. A revised nomenclature scheme, compatible with the previous serologic nomenclature scheme, was devised. A Web-accessible database describing this nomenclature and its relationship to previous schemes was established (available from: http://neisseria.org/nm/typing/pora).

PubMed Disclaimer

Figures

Figure 1

Figure 1

Alignment of the amino acid and corresponding nucleotide sequence of each VR1 family “prototype.”

Figure 2

Figure 2

Alignment of the amino acid and corresponding nucleotide sequence of each VR2 family “prototype.”

Similar articles

Cited by

References

    1. Pollard AJ, Maiden MCJ. Meningococcal disease. Totowa (NJ): Humana Press; 2001.
    1. Kuipers B, van den Dobbelsteen G, Wedege E, van Alphen L. Serological characterization. In: Pollard AJ, Maiden MC, editors. Meningococcal disease: methods and protocols. Totowa (NJ): Humana Press; 2001. p. 131–45. - PubMed
    1. Frasch CE, Zollinger WD, Poolman JT. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis. 1985;7:504–10. - PubMed
    1. Martin SL, Borrow R, van der Ley P, Dawson M, Fox AJ, Cartwright KAV. Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine. Vaccine. 2000;18:2476–81. 10.1016/S0264-410X(00)00047-5 - DOI - PubMed
    1. Jodar L, Feavers IM, Salisbury D, Granoff DM. Development of vaccines against meningococcal disease. Lancet. 2002;359:1499–508. 10.1016/S0140-6736(02)08416-7 - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources